Buonaccorsi, Janeen
Buonaccorsi, Janeen was paid $2.10M by Medicaid between Jan 2018 and Nov 2024, across 159 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 17% of everything it billed.
PEORIA, IL 61637
Next to other Dermatopathology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,324 | $223K | |
| 2019 | 44,452 | $264K | |
| 2020 | 22,666 | $164K | |
| 2021 | 32,542 | $405K | |
| 2022 | 48,493 | $525K | |
| 2023 | 38,044 | $302K | |
| 2024incomplete | 39,046 | $216K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 17% | 6,343 | 5,199 | $362K |
| 80053 | Comprehensive metabolic panel | 6.0% | 24,910 | 19,792 | $126K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.4% | 472 | 455 | $114K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.9% | 2,887 | 2,722 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.5% | 32,890 | 23,439 | $94K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.5% | 4,298 | 4,059 | $93K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.4% | 4,301 | 4,062 | $93K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 1,478 | 1,393 | $71K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 6,718 | 6,267 | $53K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.4% | 2,092 | 1,747 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 1,001 | 900 | $40K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.9% | 7,884 | 7,147 | $39K |
147 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.8% | 538 | $37K |
| 88307 | 1.7% | 734 | $36K | |
| 87510 | 1.6% | 2,770 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 8,258 | $34K |
| 87480 | 1.6% | 2,756 | $34K | |
| 88342 | 1.5% | 1,638 | $31K | |
| 83735 | 1.3% | 7,700 | $27K | |
| 82803 | 1.3% | 2,532 | $27K | |
| 87660 | 1.1% | 2,952 | $24K | |
| 87040 | 1.1% | 2,468 | $24K | |
| 87641 | 1.1% | 997 | $23K | |
| 83605 | <1% | 3,780 | $21K | |
| 82962 | <1% | 11,150 | $20K | |
| 87081 | <1% | 5,883 | $17K | |
| 84484 | <1% | 3,347 | $17K | |
| 82330 | <1% | 1,892 | $16K | |
| 80061 | Lipid panel | <1% | 4,501 | $15K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 268 | $15K |
| 88304 | <1% | 819 | $14K | |
| 88341 | <1% | 362 | $14K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 978 | $14K |
| 87186 | <1% | 2,442 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,764 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 983 | $13K |
| 85730 | <1% | 2,817 | $12K | |
| 83880 | <1% | 1,074 | $11K | |
| 86780 | <1% | 1,323 | $11K | |
| 85610 | <1% | 5,135 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,210 | $10K |
| 83690 | <1% | 2,831 | $9K | |
| 86850 | <1% | 3,007 | $9K | |
| 80069 | <1% | 2,063 | $9K | |
| 81025 | <1% | 3,909 | $8K | |
| 81001 | <1% | 5,636 | $8K | |
| 86803 | <1% | 996 | $8K | |
| 84100 | <1% | 3,524 | $8K | |
| 86901 | <1% | 3,194 | $8K | |
| 84439 | <1% | 1,780 | $8K | |
| 82607 | <1% | 1,273 | $7K | |
| 86140 | <1% | 3,053 | $7K | |
| 87581 | <1% | 317 | $7K | |
| 87088 | <1% | 1,083 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 280 | $6K |
| 87486 | <1% | 275 | $6K | |
| 86900 | <1% | 3,167 | $6K | |
| 82728 | <1% | 1,480 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 278 | $6K |
| 84466 | <1% | 1,314 | $6K | |
| 83970 | <1% | 339 | $5K | |
| 80202 | <1% | 718 | $5K | |
| 85384 | <1% | 1,506 | $5K | |
| 82784 | <1% | 700 | $5K | |
| 87340 | <1% | 726 | $5K | |
| 85379 | <1% | 1,174 | $4K | |
| 87070 | <1% | 1,337 | $4K | |
| 87147 | <1% | 2,421 | $4K | |
| 87493 | <1% | 178 | $4K | |
| 82570 | <1% | 1,676 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 507 | $4K |
| 84702 | <1% | 859 | $4K | |
| 81003 | <1% | 3,487 | $4K | |
| 83540 | <1% | 1,205 | $4K | |
| 85027 | <1% | 1,310 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 133 | $3K |
| 82550 | <1% | 1,028 | $3K | |
| 82746 | <1% | 576 | $3K | |
| 83615 | <1% | 1,096 | $3K | |
| 86038 | <1% | 396 | $3K | |
| 85014 | <1% | 2,323 | $3K | |
| 88312 | <1% | 73 | $3K | |
| 87077 | <1% | 531 | $3K | |
| 80047 | <1% | 561 | $2K | |
| 83516 | <1% | 429 | $2K | |
| 88313 | <1% | 116 | $2K | |
| 85652 | <1% | 1,792 | $2K | |
| 82805 | <1% | 134 | $2K | |
| 86920 | <1% | 445 | $2K | |
| 87205 | <1% | 932 | $2K | |
| 84703 | <1% | 519 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 60 | $2K |
| 82043 | <1% | 849 | $2K | |
| 82565 | <1% | 710 | $2K | |
| 86003 | <1% | 64 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 164 | $1K |
| 86480 | <1% | 59 | $1K | |
| 86762 | <1% | 327 | $1K | |
| 84550 | <1% | 671 | $1K | |
| 85018 | <1% | 1,185 | $1K | |
| 84478 | <1% | 553 | $1K | |
| 83655 | <1% | 204 | $1K | |
| 86706 | <1% | 166 | $1K | |
| 84481 | <1% | 242 | $1K | |
| 82247 | <1% | 463 | $1K | |
| 80074 | <1% | 57 | $1K | |
| 82248 | <1% | 517 | $997.52 | |
| 80076 | <1% | 270 | $988.94 | |
| 84132 | <1% | 558 | $870.85 | |
| 84156 | <1% | 769 | $857.22 | |
| 87807 | <1% | 137 | $748.12 | |
| 85045 | <1% | 596 | $728.38 | |
| 87075 | <1% | 107 | $728.31 | |
| 84295 | <1% | 471 | $720.26 | |
| 84146 | <1% | 108 | $688.91 | |
| 87536 | <1% | 15 | $651.75 | |
| 82951 | <1% | 87 | $545.21 | |
| 80306 | <1% | 90 | $529.51 | |
| 82947 | <1% | 402 | $505.91 | |
| 84145 | <1% | 27 | $459.94 | |
| 82785 | <1% | 84 | $418.54 | |
| 82140 | <1% | 88 | $397.35 | |
| 84480 | <1% | 75 | $314.39 | |
| 86880 | <1% | 80 | $292.90 | |
| 86431 | <1% | 88 | $286.62 | |
| 80177 | <1% | 59 | $278.92 | |
| 80164 | <1% | 50 | $254.90 | |
| 86738 | <1% | 34 | $219.30 | |
| 86308 | <1% | 84 | $217.69 | |
| 87015 | <1% | 36 | $199.49 | |
| 86360 | <1% | 13 | $183.17 | |
| 88141 | <1% | 49 | $166.47 | |
| 86200 | <1% | 34 | $165.22 | |
| 84403 | <1% | 12 | $151.68 | |
| 82950 | <1% | 69 | $149.17 | |
| 87899 | <1% | 14 | $143.00 | |
| 82274 | <1% | 26 | $139.09 | |
| 82272 | <1% | 122 | $137.57 | |
| 85049 | <1% | 142 | $135.89 | |
| 86359 | <1% | 12 | $135.84 | |
| 82533 | <1% | 17 | $127.50 | |
| 86256 | <1% | 12 | $118.00 | |
| 87184 | <1% | 29 | $117.00 | |
| 87116 | <1% | 16 | $105.30 | |
| 89051 | <1% | 37 | $101.95 | |
| 82627 | <1% | 16 | $101.68 | |
| 87341 | <1% | 18 | $97.20 | |
| 87210 | <1% | 30 | $92.83 | |
| 87427 | <1% | 14 | $86.82 | |
| 85347 | <1% | 33 | $86.58 | |
| 87045 | <1% | 14 | $85.42 | |
| 83010 | <1% | 19 | $84.17 | |
| 86376 | <1% | 14 | $60.84 | |
| 81015 | <1% | 57 | $60.26 | |
| 87102 | <1% | 14 | $52.70 | |
| 82009 | <1% | 47 | $50.70 | |
| 86403 | <1% | 14 | $48.44 | |
| 82945 | <1% | 21 | $27.72 | |
| 87046 | <1% | 14 | $16.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.